Vijaya Diagnostics Q3 results: Net profit jumps 67.3% to Rs 25.8 crore
Vijaya Diagnostics reported a profit of Rs 16.3 crore in the same period of the previous fiscal05-02-2024
05-02-2024
Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Investor Presentation
As per attachment05-02-2024
Vijaya Diagnostic Centre Ltd - 543350 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th Feb 2024
As per Attachment05-02-2024
Vijaya Diagnostic Centre Ltd - 543350 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund30-01-2024
Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company is hosting Earnings Conference call for analysts and investors on Tuesday, February 06, 2024, at 10:30 A.M. IST to discuss on the financials results of the Company for the third quarter and nine months ended December 31, 2023. The dial-in details of the call are enclosed. Please take the information on record.23-01-2024
Vijaya Diagnostic Centre Ltd - 543350 - Board Meeting Intimation for Quarterly Results
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 ,inter alia, to consider and approve 1. The Unaudited standalone and consolidated financial results of the Company for the third quarter and nine months ended December 31, 2023; and 2. Other corporate matters.23-01-2024
Vijaya Diagnostic Centre Ltd - 543350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meeting08-01-2024